Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Psoriatic disease inflammation linked to heart failure

Publish date:: July 20, 2020

Key clinical point: Inflammation control in psoriatic disease might counter heart failure risk.

Major finding: Minimum disease activity was associated with a reduced risk for heart failure (hazard ratio, 0.40).

Study details: A retrospective, single-center study of 1,994 patients with psoriatic disease who were followed for new heart failure events for a mean of 11.3 years.

Disclosures: The study was supported by the Arthritis Society. The presenter has no relevant financial disclosures.

Citation:

Koppikar S et al. GRAPPA 2020 Virtual Annual Meeting.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Cardiology

Sac/val heart failure benefit extends to diabetes patients,

Sedentary postmenopausal women have higher heart failure risk,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit,

Don’t miss cardiovascular risk factors in transgender patients,